Score Overview
Explore the 2021 public Archive ranking →
Where CryoCell International Inc has ranked, year by year
Showing 1 year ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- CCEL
2002: 10.4% · 2021: 36.6% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-29 | $ 4.05 | — |
1 Year2025-09-29 | $ 4.64 | -12.72% |
5 Years2021-09-29 | $ 9.72 | -58.34% |
10 Years2016-09-29 | $ 3.12 | 29.80% |
20 Years2006-09-29 | $ 1.89 | 113.96% |
30 Years1996-09-27 | $ 4.51 | -10.23% |
All Time1997-01-21 | $ 5.41 | -25.20% |
| Period | Last Price2026-09-29 | 1 Year2025-09-29 | 5 Years2021-09-29 | 10 Years2016-09-29 | 20 Years2006-09-29 | 30 Years1996-09-27 | All Time1997-01-21 |
|---|---|---|---|---|---|---|---|
| Price | $ 4.05 | $ 4.64 | $ 9.72 | $ 3.12 | $ 1.89 | $ 4.51 | $ 5.41 |
| Return | — | -12.72% | -58.34% | 29.80% | 113.96% | -10.23% | -25.20% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 31M | -$ 2M | $ 3M |
| 2025 | $ 31M | -$ 2M | $ 3M |
| 2024 | $ 31M | $ 402.1K | $ 3M |
| 2023 | $ 31M | -$ 9M | $ 980.25K |
| 2022 | $ 30M | $ 2M | $ 1M |
| 2021 | $ 28M | $ 2M | $ 8M |
| 2020 | $ 31M | $ 3M | $ 10M |
| 2019 | $ 31M | $ 2M | $ 7M |
| 2018 | $ 29M | -$ 854.82K | $ 6M |
| 2017 | $ 25M | $ 2M | $ 6M |
| 2016 | $ 23M | -$ 1M | $ 4M |
| 2015 | $ 21M | $ 8M | $ 4M |
| 2014 | $ 20M | $ 553.62K | $ 3M |
| 2013 | $ 18M | $ 3M | |
| 2012 | $ 17M | -$ 6M | $ 2M |
| 2011 | $ 17M | -$ 2M | $ 7M |
| 2010 | $ 17M | $ 3M | $ 9M |
| 2009 | $ 16M | $ 1M | $ 7M |
| 2008 | $ 17M | -$ 760.42K | $ 4M |
| 2007 | $ 17M | -$ 5M | $ 4M |
| 2006 | $ 17M | -$ 2M | $ 8M |
| 2005 | $ 14M | $ 1M | $ 8M |
| 2004 | $ 12M | $ 2M | $ 5M |
| 2003 | $ 7M | -$ 7M | $ 3M |
| 2002 | $ 7M | -$ 5M | $ 5M |
| 2001 | $ 5M | $ 899.63K | $ 5M |
| 2000 | $ 2M | -$ 1M | $ 3M |
| 1999 | $ 1M | -$ 600K | $ 1M |
| 1998 | $ 300K | -$ 2M | $ 500K |
| IPO1997 | $ 400K | -$ 1M | $ 800K |
CryoCell International Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 31M to $ 31M and net income went from $ 3M to -$ 2M. Revenue increased in 3 of those 5 years; net income in 2.
Across CryoCell International Inc's full reported history, from 1997 to 2025, revenue grew from $ 400K to $ 31M and net income went from -$ 1M to -$ 2M. Revenue increased in 76% of the years measured; net income in 44%.
CryoCell International Inc currently holds a 20-year HDB Score of 3.8 out of 10. How the HDB Score is calculated.
Membership
Continue CCEL’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,814 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
